Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-01-12

Clinical Trial Update: Impact of T Cells on Age-related Vascular Dysfunction: A Translational Approach [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 translational trial investigating the impact of T cells on age-related vascular dysfunction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Utah | Conditions: Cardiovascular Diseases, Inflammation | EARLY_Phase 1 | Status: WITHDRAWN